Rybelsus Cost in 2026: Now the Ozempic Pill, Here's What You'll Pay
Price verification — October 26, 2026
This article includes an older pricing snapshot. Older amounts, coupons and annual totals below are historical illustrations, not current checkout quotes.
- Wegovy (semaglutide): Wegovy tablet: $149/30 tablets at 1.5 mg, $199 at 4 mg (a temporary $149 4 mg offer may apply), and $299 at 9 mg or 25 mg. Wegovy injection: eligible new patients may pay $199 per 28-day fill for the first two fills at 0.25 or 0.5 mg through Dec. 31, 2026, then generally $349 for standard pen doses. Eligibility and dosage restrictions apply. Official source
- Clinical program fees: Ivím lists a $74.99/month membership with medication billed separately. Sesame lists care from $59/month on a 12-month commitment; month-to-month costs more, and medication is separate. These are care fees, not all-inclusive drug prices. Official source
- Sesame annual-commitment terms: Official source.
These are manufacturer self-pay or listed care-fee examples, not one all-inclusive price or guaranteed prescription. Insurers, clinical visits, pharmacy choice, dosage, supplies, refill conditions and geography can change the amount due.
If you are pricing Rybelsus in October 2026, the tablet you will actually fill in the US is the Ozempic pill. Novo Nordisk renamed and reformulated Rybelsus as Ozempic tablets (1.5 mg, 4 mg and 9 mg) starting May 4, 2026, and FDA drug shortage data lists Rybelsus 3, 7 and 14 mg as "To Be Discontinued," to be replaced by Ozempic tablets. Self-pay through NovoCare Pharmacy is $149, $199 or $299 a month depending on dose, and commercially insured patients can pay as little as $25 with Novo's savings offer, up to $100 off per month.
Key takeaways
- Rybelsus is being retired as a US brand. The same drug (oral semaglutide for type 2 diabetes) now ships as the Ozempic pill in new, lower milligram strengths.
- Self-pay prices listed by Novo: $149 for the 1.5 mg starting dose, $199 for 4 mg and $299 for 9 mg, per 30-tablet bottle.
- The commercial savings offer brings cost as low as $25, but savings top out at $100 per month and Medicare, Medicaid and other government enrollees are excluded.
- Medicare's negotiated price for semaglutide, $274 for a 30-day supply, takes effect January 1, 2027. What you pay still depends on your Part D plan.
- A switch from Rybelsus usually means a new prescription, and some plans require a new prior authorization.
Prices and program terms below are as published on the cited Novo Nordisk, FDA and CMS pages as of October 19, 2026. Verify current terms in writing with the pharmacy or plan before you fill.
What happened to Rybelsus
Novo Nordisk first announced the name change in February 2026, then confirmed in a May 1, 2026 press release that Ozempic tablets would be available to US adults with type 2 diabetes starting May 4, 2026, at more than 70,000 pharmacies. The company said Rybelsus will continue to be marketed outside the US.
The new tablet is not just a new label. Fierce Pharma reported that it is slightly smaller with a new coating, and that improved absorption allows lower milligram doses with what Novo describes as equivalent efficacy and safety.
On June 4, 2026, Novo posted all three Rybelsus strengths (3 mg, 7 mg and 14 mg) to FDA's drug shortage system with the status "To Be Discontinued." The FDA record carries this note: "Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets." FDA's drug shortage database lists semaglutide tablets under discontinuations.
Illinois Medicaid's May 21, 2026 provider notice spells out the practical timeline: Rybelsus shipments to wholesalers stop beginning in May 2026, and remaining inventory becomes limited starting in July 2026. If your pharmacy still has Rybelsus on the shelf, that supply is winding down.
Rybelsus doses and their Ozempic pill equivalents
The milligram numbers changed, which trips up a lot of price searches. The current prescribing information (revised January 2026) covers both products and states that they are "not substitutable on a mg-to-mg basis."
| Role in the label | Rybelsus (retiring) | Ozempic pill |
|---|---|---|
| Starting dose, days 1 to 30 (not effective for blood sugar control) | 3 mg | 1.5 mg |
| Maintenance dose | 7 mg | 4 mg |
| Higher maintenance dose, if more control is needed | 14 mg | 9 mg |
| Package | Bottle of 30 tablets | Bottle of 30 tablets |
Source: Rybelsus and Ozempic tablets prescribing information, rev. 1/2026.
The label says not to switch between products during the first 30 days. After that, 7 mg maps to 4 mg and 14 mg maps to 9 mg, with the new product started the day after the old one stops. Your prescriber makes that call, and the pharmacy will generally need a prescription written for Ozempic tablets. Illinois Medicaid, for example, says patients are not converted automatically and a new prescription is required.
Cash price without insurance
Novo lists self-pay prices for the Ozempic pill through NovoCare Pharmacy and select telehealth providers. These are the figures on Ozempic.com's savings page and in the May 2026 launch release.
| Product and dose | Self-pay price per month | What one month means |
|---|---|---|
| Ozempic pill 1.5 mg (starting dose) | $149 | 1 bottle, 30 tablets |
| Ozempic pill 4 mg | $199 | 1 bottle, 30 tablets |
| Ozempic pill 9 mg | $299 | 1 bottle, 30 tablets |
| Ozempic pen 0.25, 0.5 or 1 mg (for comparison) | $349 ($199 for the first 2 fills of 0.25/0.5 mg for new patients, through Dec. 31, 2026) | 1 pen |
| Ozempic pen 2 mg (for comparison) | $499 | 1 pen |
Source: Ozempic.com savings page and NovoCare Ozempic Price Guide (May 2026). Eligibility and restrictions apply.
Two cautions. First, a self-pay purchase happens outside your insurance, so Novo says it cannot be submitted for reimbursement or counted toward your deductible or out-of-pocket maximum. Second, Novo reserves the right to change or end these programs at any time, so treat the price as current, not guaranteed.
Paying cash for a GLP-1?
Compare current self-pay options before choosing a program.
Paid links. We may earn a commission; it never changes what we write. See all options. Compounded medications are not FDA-approved.
With commercial insurance: the $25 offer and its $100 ceiling
Novo's savings offer for the Ozempic pill and pen works like this, per Ozempic.com:
- Pay as little as $25 for any dose, for up to a 3-month prescription.
- Maximum savings of $100 per month (one month = one 30-tablet bottle).
- Valid for up to 48 months.
- Requires commercial coverage for Ozempic. Medicare Part D, Medicaid and other government beneficiaries are excluded.
The $100 ceiling is what decides your real cost. If your plan charges $125 or less for a month, you pay $25. Above $125, the card takes off $100 and you pay the rest, for example while you are still in a deductible.
| Your plan's charge for one bottle (illustration) | Card covers | You pay |
|---|---|---|
| $45 copay | $20 | $25 |
| $125 copay | $100 | $25 |
| $200 coinsurance | $100 | $100 |
| $500 while in your deductible | $100 | $400 |
Illustrative math only, applying the $25 floor and $100 monthly cap from Ozempic.com's offer terms. Your plan's actual charge depends on its formulary and deductible.
The name change can also affect coverage paperwork. The Ozempic pill has its own product codes, and some plans treat it as a new request. Illinois Medicaid keeps Ozempic tablets preferred with prior authorization for type 2 diabetes but requires a new PA request. Commercial plans set their own rules, so ask before your Rybelsus supply runs out.
With Medicare Part D
The $25 savings offer does not apply to Medicare. Your cost comes from your Part D plan's tier for the Ozempic pill, within federal limits. According to Medicare.gov, no Part D deductible can exceed $615 in 2026 or $700 in 2027, and once your out-of-pocket spending reaches $2,100 in 2026 ($2,400 in 2027), you pay nothing more for covered Part D drugs for the rest of that year.
The bigger change arrives January 1, 2027. Semaglutide (Ozempic, Rybelsus and Wegovy, negotiated together) was one of the drugs in Medicare's second round of price negotiation. CMS put the negotiated price at $274 for a 30-day supply, 71% below the 2024 list price of $959. CMS lists $276.78 for 30 Rybelsus 7 mg tablets. Because Rybelsus is being replaced, ask your plan how the Ozempic pill will be priced under that agreement in 2027.
Novo is also cutting list prices. Novo Nordisk said in a February 24, 2026 release that the monthly list price of Rybelsus 7 mg and 14 mg tablets, along with Wegovy and Ozempic, will drop to $675 effective January 1, 2027. A lower list price matters most if your plan charges coinsurance (a percentage) rather than a flat copay.
Novo's Patient Assistance Program changed for 2026: per NovoCare, Medicare enrollees with Part D coverage are no longer eligible for Ozempic through the program, and uninsured applicants qualify for Ozempic only at or below 200% of the federal poverty level. The page does not specifically address the Ozempic pill, so confirm with NovoCare whether it is on the current product list.
How the Ozempic pill differs from the Wegovy pill
Both are oral semaglutide from Novo, and both are taken the same way: one tablet on an empty stomach in the morning with up to 4 ounces of water, then a 30-minute wait. They are still different products with different coverage paths.
- Indication. The Ozempic pill is for adults with type 2 diabetes, to improve blood sugar control and reduce major cardiovascular events in those at high risk, per its label. The Wegovy label covers weight reduction in adults with obesity or overweight plus a weight-related condition, and cardiovascular risk reduction in adults with established heart disease and obesity or overweight.
- Doses. The Ozempic pill tops out at 9 mg today. Novo has filed for a 25 mg Ozempic tablet and expects an FDA decision by the end of 2026.
- Insurance. Diabetes drugs are routinely on formularies; weight-loss drugs are often excluded. A Wegovy pill prescription does not inherit Ozempic pill coverage, or the reverse.
- Combining. The Wegovy label says using it with other semaglutide products is not recommended.
What to do if you take Rybelsus now
- Check how many refills of Rybelsus your pharmacy can still fill, given the inventory wind-down.
- Ask your prescriber about a new prescription for the equivalent Ozempic pill dose (7 mg to 4 mg, 14 mg to 9 mg, per the label).
- Call your plan to confirm the Ozempic pill's tier and whether a new prior authorization is needed.
- If you have commercial insurance, activate the savings offer and compare your plan copay against the $100 monthly cap.
- If you are uninsured, compare NovoCare's self-pay price with Novo's assistance program eligibility.
- Get any quoted price or approval in writing before the fill.
Questions to ask your plan or pharmacist
- Is the Ozempic pill on my formulary, and at what tier?
- Does my existing Rybelsus approval transfer, or do I need a new prior authorization?
- Is my cost a flat copay or a percentage of the price?
- For Medicare: what will my 2027 cost be under the negotiated semaglutide price?
- Can I fill 90 days at once, and does that change my cost?
Coverage denied or too expensive?
Compare care options and current self-pay prices before choosing a program.
Paid links. We may earn a commission; it never changes what we write. See all options. Compounded medications are not FDA-approved.
Frequently asked questions
Is Rybelsus discontinued in the US?
Yes. Novo Nordisk renamed and reformulated it as the Ozempic pill starting May 4, 2026, and FDA drug shortage data lists Rybelsus 3, 7 and 14 mg as 'To Be Discontinued,' to be replaced by Ozempic tablets. Rybelsus continues to be sold outside the US.
How much does the Ozempic pill cost without insurance?
Novo lists self-pay prices of $149 for the 1.5 mg starting dose, $199 for 4 mg and $299 for 9 mg per 30-tablet bottle through NovoCare Pharmacy and select telehealth providers. Self-pay purchases do not count toward an insurance deductible.
What Ozempic pill dose replaces my Rybelsus dose?
The prescribing information maps Rybelsus 7 mg to Ozempic tablets 4 mg and 14 mg to 9 mg, and says not to switch during the first 30 days. The products are not interchangeable mg for mg, so the switch should go through your prescriber.
Can I use the Ozempic savings card with Medicare?
No. The $25 offer requires commercial insurance and excludes Medicare Part D, Medicaid and other government beneficiaries. Medicare costs depend on your Part D plan, with an out-of-pocket limit of $2,100 in 2026 and $2,400 in 2027.
What is the Medicare negotiated price for Rybelsus?
CMS's negotiated price for semaglutide (Ozempic, Rybelsus and Wegovy) is $274 for a 30-day supply, effective January 1, 2027. Your actual copay still depends on your Part D plan.
Sources
- Novo Nordisk: Ozempic pill available to US adults with type 2 diabetes (May 1, 2026)
- Fierce Pharma: Rybelsus brand officially retired in US (May 1, 2026)
- FDA drug shortage data (openFDA): Rybelsus 3, 7, 14 mg "To Be Discontinued," posted June 4, 2026
- FDA Drug Shortages: Semaglutide Tablets (discontinuation)
- Illinois HFS provider notice: Rybelsus to Ozempic tablet transition (May 21, 2026)
- Rybelsus and Ozempic (semaglutide) tablets prescribing information (rev. 1/2026)
- Ozempic.com: Save on Ozempic (savings offer and self-pay prices)
- NovoCare: Ozempic Price Guide (May 2026)
- Medicare.gov: Costs for Medicare drug coverage
- CMS: Medicare GLP-1 Bridge
- NovoCare: Patient Assistance Program
- Wegovy (semaglutide) prescribing information (rev. 6/2026)
- CMS: Negotiated Prices for Initial Price Applicability Year 2027 fact sheet
- Novo Nordisk press release: Significant reduction in US list price for Wegovy, Ozempic and Rybelsus (Feb. 24, 2026, via BioSpace)
Medical disclaimer: This article is general information, not medical advice, and does not replace a licensed clinician who knows your history. Approvals, labels, coverage and prices change; check the linked sources and talk with your prescriber or pharmacist before making decisions about any medication.